Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J H Porter

Showing results (21-30 of 231) with videos related to

Pageof 24
Sort By:
Advanced Drug Delivery Reviews|December 25, 2007
Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic updateNatalie L Trevaskis, William N Charman, Christopher J H Porter
Drug Discovery Today. Technologies|July 2, 2014
Subcutaneous drug delivery and the role of the lymphaticsDanielle N McLennan, Christopher J H Porter, Susan A Charman
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 10, 2006
An examination of the interplay between enterocyte-based metabolism and lymphatic drug transport in the ratNatalie L Trevaskis, Christopher J H Porter, William N Charman
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 8, 2014
Nano-chemotherapeutics: maximising lymphatic drug exposure to improve the treatment of lymph-metastatic cancersGemma M Ryan, Lisa M Kaminskas, Christopher J H Porter
Molecular Pharmaceutics|October 21, 2010
Targeted drug delivery to lymphocytes: a route to site-specific immunomodulation?Natalie L Trevaskis, William N Charman, Christopher J H Porter
Biopharmaceutics & Drug Disposition|April 17, 2003
Does stereoselective lymphatic absorption contribute to the enantioselective pharmacokinetics of halofantrine In Vivo?David M Shackleford, Christopher J H Porter, William N Charman
AAPS Pharmsci|March 21, 2003
An in vitro examination of the impact of polyethylene glycol 400, Pluronic P85, and vitamin E d-alpha-tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein efflux and enterocyte-based metabolism in excised rat intestineBrendan M Johnson, William N Charman, Christopher J H Porter
Nanomedicine (London, England)|September 30, 2011
Dendrimer pharmacokinetics: the effect of size, structure and surface characteristics on ADME propertiesLisa M Kaminskas, Ben J Boyd, Christopher J H Porter
Molecular Pharmaceutics|October 15, 2011
Correction to "targeted drug delivery to lymphocytes: a route to site-specific immunomodulation?"Natalie L Trevaskis, William N Charman, Christopher J H Porter
Nature Reviews. Drug Discovery|October 17, 2015
From sewer to saviour - targeting the lymphatic system to promote drug exposure and activityNatalie L Trevaskis, Lisa M Kaminskas, Christopher J H Porter
Pageof 24

Showing results (21-30 of 231) with videos related to

Sort By:
Pageof 24
Advanced Drug Delivery Reviews|December 25, 2007
Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic updateNatalie L Trevaskis, William N Charman, Christopher J H Porter
Drug Discovery Today. Technologies|July 2, 2014
Subcutaneous drug delivery and the role of the lymphaticsDanielle N McLennan, Christopher J H Porter, Susan A Charman
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 10, 2006
An examination of the interplay between enterocyte-based metabolism and lymphatic drug transport in the ratNatalie L Trevaskis, Christopher J H Porter, William N Charman
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 8, 2014
Nano-chemotherapeutics: maximising lymphatic drug exposure to improve the treatment of lymph-metastatic cancersGemma M Ryan, Lisa M Kaminskas, Christopher J H Porter
Molecular Pharmaceutics|October 21, 2010
Targeted drug delivery to lymphocytes: a route to site-specific immunomodulation?Natalie L Trevaskis, William N Charman, Christopher J H Porter
Biopharmaceutics & Drug Disposition|April 17, 2003
Does stereoselective lymphatic absorption contribute to the enantioselective pharmacokinetics of halofantrine In Vivo?David M Shackleford, Christopher J H Porter, William N Charman
AAPS Pharmsci|March 21, 2003
An in vitro examination of the impact of polyethylene glycol 400, Pluronic P85, and vitamin E d-alpha-tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein efflux and enterocyte-based metabolism in excised rat intestineBrendan M Johnson, William N Charman, Christopher J H Porter
Nanomedicine (London, England)|September 30, 2011
Dendrimer pharmacokinetics: the effect of size, structure and surface characteristics on ADME propertiesLisa M Kaminskas, Ben J Boyd, Christopher J H Porter
Molecular Pharmaceutics|October 15, 2011
Correction to "targeted drug delivery to lymphocytes: a route to site-specific immunomodulation?"Natalie L Trevaskis, William N Charman, Christopher J H Porter
Nature Reviews. Drug Discovery|October 17, 2015
From sewer to saviour - targeting the lymphatic system to promote drug exposure and activityNatalie L Trevaskis, Lisa M Kaminskas, Christopher J H Porter
Pageof 24